An Act relative to colon cancer screening
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill expands access to colorectal cancer screening in Massachusetts. It mandates coverage for various screening methods, including flexible sigmoidoscopy, FIT tests, and colonoscopy, starting at age 30 for state employees, Medicaid recipients, and individuals with private health insurance. Importantly, the screenings will not require cost-sharing, such as co-pays or deductibles, ensuring affordability for those covered.
Key provisions
- Provides colorectal cancer screening coverage starting at age 30 for state employees, Medicaid recipients, and individuals with private health insurance.
- Specifies a range of screening methods, including flexible sigmoidoscopy, FIT tests, KRAS/BRAF tests, FIT-DNA tests, HSgFOBT, CT colonography, and colonoscopy.
- Eliminates co-pays, deductibles, and coinsurance for colorectal cancer screening services.
- Extends coverage to individuals enrolled in various health plans, including those under the group insurance commission, Medicaid, and employers’ health and welfare funds.
- Defines ‘colonoscopy’ for the purposes of the bill.
- Applies to contracts with health insurers and health maintenance organizations.
- Includes provisions for coverage under blanket or general policies of insurance.
Who is affected
- State Employees
- Medicaid Recipients
- Individuals with Private Health Insurance
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
7 on record
Primary sponsor
Joint Committee on Financial Services
Cosponsors
James Arciero
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours